Page last updated: 2024-08-25

ropivacaine and Acantholysis Bullosa

ropivacaine has been researched along with Acantholysis Bullosa in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Bellon, N; Bodemer, C; Chaumon, S; Corset, I; Elie, C; Greco, C; Moreno Artero, E; Rabeony, T; Schinkel, N1
Casagrande, F; Chambelland, A; Chiaverini, C; Devos, C1

Other Studies

2 other study(ies) available for ropivacaine and Acantholysis Bullosa

ArticleYear
Efficacy of topical ropivacaine in children and young adults with hereditary epidermolysis bullosa.
    The British journal of dermatology, 2021, Volume: 184, Issue:3

    Topics: Child; Epidermolysis Bullosa; Epidermolysis Bullosa Dystrophica; Humans; Ropivacaine; Young Adult

2021
Topical ropivacaine for analgesia of aplasia cutis congenita in newborns with hereditary epidermolysis bullosa.
    Orphanet journal of rare diseases, 2020, 12-01, Volume: 15, Issue:1

    Topics: Analgesia; Child; Ectodermal Dysplasia; Epidermolysis Bullosa; Humans; Infant, Newborn; Pain; Prospective Studies; Ropivacaine

2020